Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

244.54
-6.5600-2.61%
Post-market: 244.540.00000.00%19:30 EDT
Volume:1.19M
Turnover:293.91M
Market Cap:15.87B
PE:16.72
High:250.64
Open:249.48
Low:244.49
Close:251.10
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.62
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.31
PE(LYR):-41.87

Loading ...

Aug 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 26, 2026

Major Issues Report

Form 8-K - Current report
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 24, 2026

Major Issues Report

Form 8-K - Current report
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2026

Major Issues Report

Form 8-K - Current report
May 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2026

Major Issues Report

Form 8-K - Current report